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Abstract Longitudinal data gathered from health surveillance, when combined with detailed demographic information, can provide 
invaluable insight into disease outcomes. Many such surveillance sites exist in the developing world, particularly in Asia and 
sub-Saharan Africa, and focus on diseases such as HIV/AIDS, cholera, malaria and tuberculosis. The indistinct positions of such 
surveillance systems, often inhabiting an area between research, treatment and population health monitoring, means that the 
necessity of and responsibility for ethical oversight is unclear. This regulatory vacuum is further compounded by a lack of attention 
to longitudinal surveillance systems in ethics literature. In this paper, we explore some key ethical questions that arise during 
demographic and health surveillance in relation to ethical principles of beneficence, respect for persons and justice: health-care 
provision, informed consent and study sustainability.
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Une traduction en français de ce résumé figure à la fin de l’article. Al final del artículo se facilita una traducción al español. الرتجمة العربية لهذه الخالصة يف نهاية النص الكامل لهذه املقالة.
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Introduction
Gross health inequalities between the 
developed and developing world drive 
the activities of researchers and public-
health practitioners worldwide. The 
need for empirical evidence to guide 
further research and to direct health 
interventions is acute, as reliable data 
is in short supply and is often based 
on indirect estimates or geographically 
limited to urban areas.1 In developing 
countries, and in particular those that 
lack effective vital registration systems, 
small-scale combined Demographic 
and Health Surveillance (DHS) systems 
can provide invaluable field data on 
longitudinal fertility and mortality 
patterns.1–4 DHS systems are distinct 
from demographic and health surveys. 
The former represent long-term 
monitoring of specifically defined 
populations, typically residing in a small 
geographic region, while the latter are 
one-time representative samplings of 
a country or region.5 Though the data 
collected in surveillance and surveys 
is similar in scope, the timeframe and 
populations studied are quite different.
Located primarily in Africa and 
Asia, DHS are effective and compre-
hensive data collection systems because 
they focus on the populations of small, 
clearly delineated geographic areas. 
Central to all DHS is continuous de-
mographic surveillance, consisting of 
initial and repeat censuses of the chosen 
population, registering each individual 
resident and recording their associated 
information, such as socioeconomic 
and behavioural data.6,7 Health out-
comes and vital events in the area are 
then linked to individual demographic 
records for precise, rather than esti-
mated, data on fertility, morbidity, mor-
tality and migration.8 Research findings 
and interventions that have emerged 
from DHS in the decades since World 
War Two include the development of 
oral rehydration solution; vaccine ef-
ficacy trials for measles, cholera and 
tetanus; an understanding of the rela-
tionship between cessation of breast-
feeding and malnutrition; and data 
on the effects of environmental altera-
tion on human health.7,9 Because DHS 
study sites are typically chosen for their 
high rates of infectious disease or their 
fertility patterns,8 the interventions and 
findings that are associated with DHS 
have direct impact on the health and 
wellbeing of the populations under 
study.
Such findings are the primary jus-
tification for the intense monitoring 
associated with DHS. The utility to 
public health of surveillance data and 
health interventions that benefit both 
the local community and global popula-
tions is weighed against potential risks 
to individuals.4 Such considerations of 
individual risk versus community ben-
efit, commonly found in medical and 
research ethics, are in the DHS context 
rendered more complex by the am-
biguous position of surveillance, which 
transcends traditional distinctions be-
tween research, care and monitoring. 
While the potential for DHS data to 
increase global health equity and local 
public health is genuine, the ethical 
pitfalls associated with decades-long, 




Balancing general welfare and individual 
rights is the backbone of ethical 
regulations regarding the use of human 
subjects in research. The principles of 
respect for persons, beneficence and 
justice outlined in the 1979 Belmont 
Report are broad categories designed 
to guide researchers in their selection 
and treatment of human subjects.10 The 
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Belmont Report differentiates between 
medical practice and research but no 
provision is made for surveillance. 
Surveillance spans practice and research, 
neither providing treatment for the 
benefit of individuals nor hypothesis 
testing. Activities accompanying DHS, 
such as provision of medical care or 
vaccine trials, clearly fall into the two 
categories of practice and research, but 
what about surveillance?
Helping researchers navigate the 
ethical issues arising in longitudinal 
DHS systems is the guidance issued by 
the Council for International Organi-
zations of Medical Sciences (CIOMS) 
and the recommendations developed 
by the International Network of field 
sites with continuous Demographic 
Evaluation of Populations and Their 
Health (INDEPTH), along with the 
activities of individual ethics commit-
tees and institutional review boards. 
CIOMS’s newly developed epidemiol-
ogy guidelines address observational or 
other studies that take place at a com-
munity or population level, but suggest 
that standards applied to biomedical 
research emphasizing individual-level, 
informed and culturally-sensitive con-
sent are also largely applicable in epide-
miological research.11 The INDEPTH 
Network is a member organization of 
37 DHS systems worldwide, located in 
19 countries and representing a moni-
tored population of over 2.5 million.12 
Chartered in 1998 in recognition 
of both the great potential of DHS 
systems and the difficulty in situating 
DHS within broader ethical and regu-
latory frameworks, one of INDEPTH’s 
primary goals is to facilitate results 
and best-practice exchange between 
longitudinal population surveillance 
systems.13
A portion of INDEPTH’s capac-
ity-building programme involves pro-
viding training documents for parties 
interested in initiating or improving 
an ongoing study. INDEPTH recom-
mends that any parties interested in 
starting a DHS need to establish three 
committees: a scientific advisory com-
mittee, a management committee and 
an institutional review board.14 In ad-
dition to these guidelines, INDEPTH 
has formed an ethical practice working 
group to explore and address the ethi-
cal difficulties associated with surveil-
lance activities.6 However, aside from 
these resources, in general a regulatory 
vacuum remains in regard to longitudi-
nal surveillance systems that is further 
compounded by a lack of attention 
to this domain in current bioethics, 
research ethics and public-health eth-
ics literature. In this paper, we aim to 
contribute to an ethics of longitudinal 
health surveillance by briefly explor-
ing three key ethical challenges that 
arise during the creation, maintenance 
and conclusion of longitudinal DHS 
systems and that are closely associated 
with the fundamental ethical principles 
of beneficence, respect for persons and 
justice: provision of health care, in-
formed consent and surveillance system 
sustainability. As we will indicate, many 
of the problems faced by DHS involve 
conflicts between these three ethical 
principles.
Beneficence and health-care 
provision
While the provision of health care 
falls under the ethical obligations of 
practice, in the case of DHS systems 
it is complicated by its entanglement 
with ongoing surveillance activities. 
Many DHS are affiliated with local 
health-care organizations,6 and some 
operate their own medical facilities, 
such as the International Centre for 
Diarrhoeal Disease Research, Bangladesh 
(ICDDR,B) Matlab DHS.15 Though 
some health facilities predate the DHS 
activities, the link between provision of 
care and surveillance can be ethically 
problematic. How can a DHS do no 
harm, maximize benefits and minimize 
risks to the study population in regards 
to health-care provision?
If health care is associated with the 
DHS, decisions must be made regard-
ing whether to treat only the diseases 
of focus and whether to treat only 
study participants. In the treatment of 
diseases that constitute the primary 
focus of the DHS systems, such as 
diarrhoeal diseases in the ICDDR,B 
Matlab study15 or HIV/AIDS in the 
Rakai, Uganda DHS,16 providers must 
strike a balance between caring for the 
population under surveillance while 
not overly impacting the topic of 
study. While providing treatment for 
individuals is a less ethically problem-
atic option, since their conditions have 
been identified and recorded, non- 
interventionist observation may pro-
duce data that could improve popula-
tion health.4 In this sense, DHS often 
face ethical conflicts between short- 
and long-term beneficence. For exam-
ple, in the case of Matlab, the incidence 
of diarrhoeal diseases has drastically 
declined since the initiation of care 
under the DHS auspices.17 While im-
provement of local population health 
is certainly a goal of DHS systems, de-
clining incidence of events of interest 
means less data and less information 
on patterns that could be occurring in 
untreated areas elsewhere in the coun-
try. When the justification for intense 
longitudinal surveillance is the reli-
ability of information on health and 
demographic patterns, changes in the 
study area that are not mirrored in the 
surrounding area can threaten the rea-
son for existence of a DHS.
In addition to providing treatment 
for topics of DHS interest, decisions 
must also be made concerning the 
provision of ancillary care. Ancillary 
care is defined as “positive obligations 
to provide care that participants need, 
but that is required neither to success-
fully answer the researchers’ scientific 
question nor to avoid or mitigate harm 
resulting from participation in the 
research.”18 In the majority of DHS 
sites, levels of health need are high and 
therefore the question of whether an-
cillary care should be provided arises 
continually. Belsky & Richardson19 
argue that the extent of ancillary care 
provided ought to be dependent on 
several factors, including participant 
vulnerability and the duration of the 
relationship, and that funding for an-
cillary treatment should be built into 
initial budgets. From this perspective, 
the obligation to provide ancillary 
care on the part of surveillance agen-
cies would seem to be very substantial 
since they monitor the health of poor 
and unhealthy communities for de-
cades. DHS budgets would have to 
be increased substantially to meet the 
demand for ancillary care, raising the 
vexing question of where the responsi-
bility of DHS ends and that of the local 
health-care system begins. Increasing 
the DHS budget for ancillary care also 
raises questions of justice if the DHS 
surveillance population receives sub-
stantially better health care than the 
general population.
In addition to the issues regarding 
whether and to what extent ancillary 
health care should be provided by 
DHS, the question of “who to treat” 
raises ethical and economic dilemmas. 
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Although DHS confine their data col-
lection to specific communities, disease 
does not respect such boundaries. 
Social networks that extend past DHS 
boundaries or infectious agents that 
move through the environment make 
study borders arbitrary. Some DHS, 
such as ICDDR,B’s Matlab, provide 
free treatment for a range of conditions 
to anyone who requests it, but only 
those patients who are DHS partici-
pants have their health records linked 
to their demographic information.
Respect for persons and 
informed consent
Stringent requirements for voluntary 
informed consent have been developed 
to protect the autonomy of human 
subjects in research activities, and the 
close interaction between surveillance 
systems’ individual-level data collection 
and associated research studies makes 
the process of consent appropriate 
with DHS participants. However, the 
complications in the consent process 
specific to surveillance activities – 
related to conception of autonomy, the 
position of individuals within households 
and communities, and the multi- 
generational nature of longitudinal 
surveillance – have received only slight 
attention in the surveillance ethics 
literature.
For example, full community par-
ticipation is essential to DHS since 
surveillance is only effective when the 
entire population is monitored and 
accurate information on demographic 
and health patterns can be gathered.20 
However, this need for total coop-
eration can threaten the ability of in-
dividuals or households to make truly 
autonomous opt-in decisions. It is con-
ceivable that those who have already 
agreed to participate in surveillance 
will regard other households expressing 
reluctance as threats to the possibility 
of free health-care provision or other 
community-accrued benefits. A DHS 
must find acceptable strategies to alle-
viate tension among community mem-
bers who disagree over the proposed 
surveillance.
Where data collection structures 
are often organized at three levels: the 
residential unit, the household and 
the individual, concerns are raised over 
who precisely is consenting to partici-
pation.6 Does consent need to be ob-
tained from every individual, or every 
household, or will residential unit suf-
fice? Community consent to participate 
is often the first step in choosing the 
site of a DHS: if there is no community 
agreement to take part in surveillance 
then another location must be found. 
But community consent is far from 
sufficient given the intense scrutiny of 
the DHS on individual and household 
lives. Is consent at the household level 
adequately respectful of individual au-
tonomy? While household-level con-
sent would likely be rejected in surveil-
lance studies held in developed coun-
tries, the location of DHS in developing 
countries (where values of autonomy 
may be partly or not at all present) 
could make this a feasible alternative 
to individually obtaining consent from 
thousands or tens of thousands of resi-
dents. But is it ethical for a male head 
of household to consent for his entire 
family to participate in surveillance? 
And would choosing household over 
individual consent express cultural sen-
sitivity or “ethical double standards”?
In addition to questions of indi-
vidual versus household consent, dura-
tion of consent raises ethical questions 
unique to surveillance systems. While 
research protocols typically outline a 
specific start and end point for con-
senting activities or sample usage, de-
mographic and health surveillance can 
continue for decades. DHS administra-
tors must consider whether previously 
obtained consent counts as consent for 
future members of the household. 
For instance, in studies initiated in 
the 1960s with continuous household 
participation (e.g. the Niakhar, Senegal 
DHS),21 does the consent of a grandfa-
ther extend to his children and grand-
children even if they were not alive at 
the time the study began? Although 
central to research ethics, re-obtaining 
consent from households annually 
would likely be too expensive and time 
consuming for DHS administrators. 
Obtaining consent from successive 
generations could be feasible and pro-
tective of DHS participants, though 
questions remain concerning when to 
ask new generations for consent (e.g. 
in adolescence or age of majority). Fur-
thermore, even if given the option of 
opting-out of surveillance, it is possible 
that individuals whose households and 
community have participated for years 
might not feel that leaving the DHS is 
a legitimate decision.
A further, related complication to 
the consent process in DHS is that, over 
time, the division between research and 
treatment may be blurred in the mind 
of participants who do not distinguish 
between the DHS as a care/surveillance 
organization and the DHS as a research 
entity. The INDEPTH Network advises 
that when approaching a community 
as a possible site for a DHS, commu-
nity members must be alerted that they 
“might be called upon from time to 
time to assist carrying out certain [re-
search] activities” beyond the scope of 
surveillance.14 While DHS participants 
are always asked to consent to a research 
protocol, it is conceivable that DHS 
with adults who were raised entirely 
within the surveillance period could 
feel that any requests from DHS per-
sonnel are legitimate or obligatory. 
Researchers working with DHS popu-
lations must strive, perhaps more than 
during other kinds of health research, 
to develop approaches that balance 
autonomy and beneficence, i.e. provide 
adequate assurance of voluntary and 
autonomous participation without 
negative repercussions on access to 
study benefits.
Justice and study 
sustainability
Changes to or dissolution of a surveil-
lance system raise issues of justice, per-
taining particularly to the continuation 
of care or other benefits afforded by 
surveillance participation. While DHS 
boundaries are determined at study on-
set, what happens if a DHS decides to 
shrink the study area? Will health care 
and other benefits still be provided to 
DHS “alumni” who have been phased 
out? In the case of DHS that provide 
health care regardless of participation 
status, shrinking study boundaries will 
have little to no effect on benefits af-
forded to former participants. However, 
in DHS systems that do not provide 
health services to non-study popula-
tions, should former survey participants 
receive study benefits when they are no 
longer providing personal information? 
Consent to participate in DHS does 
not usually delineate a specific time-
frame of benefits received. Although 
few studies mention during surveil-
lance initiation what will happen at the 
end of the process, perhaps the ethical 
course for DHS administrators would 
be to advise prospective participants 
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Résumé
Surveillance démographique et sanitaire : considérations éthiques longitudinales
Combinées à des données démographiques détaillées, les données 
longitudinales recueillies par la surveillance sanitaire peuvent 
donner un aperçu extrêmement précieux des résultats sanitaires. 
Il existe de nombreux sites assurant une telle surveillance dans le 
monde en développement, notamment en Asie et en Afrique sub-
saharienne, qui se focalisent sur des maladies comme le VIH/sida, 
le choléra, le paludisme ou la tuberculose. La position floue de ces 
systèmes de surveillance, souvent à cheval entre la recherche, le 
traitement et la surveillance sanitaire des populations, fait que les 
besoins et les responsabilités en matière de surveillance éthique 
sont peu clairs. Ce vide réglementaire est en outre aggravé par un 
manque d’intérêt pour les systèmes de surveillance longitudinale 
dans la littérature consacrée à l’éthique. Nous explorons dans cet 
article certaines questions éthiques essentielles, soulevées par 
la surveillance démographique et sanitaire en relation avec les 
principes éthiques de bienveillance, de respect des personnes 
et de justice, à savoir : la dispensation de soins de santé, le 
consentement éclairé et la durabilité des études.
about what they can expect if or when 
the DHS no longer requires their par-
ticipation.
Issues of study sustainability per-
tain not only to decreasing survey 
boundaries but also to ethical obliga-
tions when a DHS ends surveillance. 
While DHS foci of infectious disease, 
malnutrition and maternal health are 
unlikely to vanish soon, it is entirely 
possible that DHS funding will disap-
pear or that a DHS will decide to move 
locations because health patterns have 
substantially changed in the current 
location. In such cases, does the DHS 
have an ethical obligation to provide 
health care even when it is no longer 
collecting data from a population? 
Or do the benefits a community has 
already accrued, such as prior health 
care, increased health education, 
worker training, or improved infra-
structure, constitute a mutual exchange 
that renders a DHS free from future 
obligation, as suggested by the “fair 
benefits” framework? 22 Analyses of 
these problems from a research stand-
point (particularly in terms of HIV/
AIDS research) have concluded that 
guaranteed post-study treatment, as 
reciprocity for participation, does not 
resolve the problem because one popu-
lation can still be unfairly privileged 
over another.23 Perhaps, in the case of 
DHS, if the surveillance and care net-
works remain in place the best option 
would be to work with the Ministry of 
Health to gradually turn these services 
over to the local or national govern-
ment. However, this requires an active 
and participatory national government 
with funding to continue providing 
services, a tall order in many resource-
strapped developing countries.
Conclusion
While longitudinal DHS systems 
focusing on small ,  wel l-defined 
communities can provide invaluable 
information on health patterns and 
behaviours,2 their need for the intense 
study of specific populations raises 
many ethical questions. While we have 
addressed some of those questions that 
relate to the provision of care in DHS, 
to the informed consent process and to 
changes in study activities, many more 
remain. Balancing risks and benefits to 
research participants and communities 
is typically a delicate task but the addition 
of long-term surveillance activities adds 
another level of complexity. While 
current DHS utilize ethics committees 
to review research activities taking place 
among study populations, there are also 
serious ethical questions that are raised 
by the initiation, maintenance and 
conclusion of surveillance: processes 
that are not necessarily considered under 
standard ethical review. Perhaps there is 
a need for a supranational organization, 
distinct from institutions such as 
CIOMS, dedicated to advising and 
regulating ethical aspects of population- 
based surveillance. Though each DHS 
site would have ethical questions specific 
to local populations and surveillance 
foci, overarching questions related to 
beneficence, respect for persons and 
justice as outlined in this paper would 
be applicable across sites. However, in 
the interim, the need for accurate data 
to assess health interventions and the 
needs of general populations over the 
rights of individuals do not exempt 
demographic and health surveillance 
from facing difficult ethical questions 
and protecting the dignity and safety of 
participants.  ■
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Resumen
Consideraciones éticas en los sistemas longitudinales de vigilancia demográfica y sanitaria
Los datos longitudinales aportados por la vigilancia sanitaria, 
cuando se combinan con datos demográficos detallados, pueden 
ofrecer una información inestimable sobre la evolución de las 
enfermedades. En el mundo en desarrollo, sobre todo en Asia y 
el África subsahariana, hay muchos sitios de vigilancia centrados 
en enfermedades como el VIH/SIDA, el cólera, la malaria y la 
tuberculosis. La función poco definida de esos sistemas de 
vigilancia, en los que se solapan con frecuencia la investigación, 
el tratamiento y la vigilancia sanitaria de la población, lleva parejo 
un dudoso reconocimiento de la necesidad de una labor de 
supervisión ética y de la responsabilidad de tal labor. Ese vacío 
normativo se ve agravado por la indiferencia mostrada hacia los 
sistemas de vigilancia longitudinal en las publicaciones sobre 
ética. En el presente artículo se analizan algunas cuestiones 
éticas relevantes que plantean la vigilancia demográfica y 
sanitaria en relación con los principios éticos de beneficencia, 
respeto a las personas y justicia: prestación de atención sanitaria, 
consentimiento informado y sostenibilidad de los estudios.
ملخص
د الدميغرايف والصحي: اعتبارات أخالقية طوالنية التـرصُّ
وبني  الصحي  د  التـرصُّ عن  الناتجة  الطوالنية  البيانات  بني  الجمع  شأن  من 
لة، أن يقدم أفكارا قيِّمة حول الحصائل املرضية.  املعلومات الدميغرافية املفصَّ
آسيا  يف  والسيَّام  هذه،  د  التـرصُّ مواقع  من  العديد  النامي  العامل  يف  ويوجد 
ز عىل أمراض مثل اإليدز والعدوى  وبلدان أفريقيا جنوب الصحراء، وهي تـركِّ
د هذه،  التـرصُّ لُنُظم  املبهم  الوضع  أما  بفريوسه، والكولريا، واملالريا، والسل. 
السكان،  صحة  ورصد  واملعالجة  البحوث  بني  مجاالً  تشغل  ما  عادًة  والتي 
فيعني أن الحاجة إىل الرقابة األخالقية واملسؤولية عنها غري واضحة. ويتفاقم 
د  التـرصُّ بُنُظم  االهتامم  نقص  جراء  من  فأكرث  أكرث  التنظيمي  الفراغ  هذا 
الطوالنية يف الدراسات املنشورة حول الضوابط األخالقية. ويستطلع الباحثون 
د  التـرصُّ أثناء  تنشأ  التي  الرئيسية  األخالقية  املسائل  بعض  الورقة  هذه  يف 
الدميغرايف والصحي يف ما يتعلَّق باملبادئ األخالقية للخري، واحتـرام األشخاص، 
علم  عىل  املرتكزة  املستنرية  واملوافقة  الصحية،  الرعاية  تقديم  والعدالة: 
الع، واستمرارية الدراسة. واطِّ
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